Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2010

01-04-2010 | Article

Molecular fingerprinting of Staphylococcus aureus from bone and joint infections

Authors: C. Luedicke, P. Slickers, R. Ehricht, S. Monecke

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2010

Login to get access

Abstract

The objective of the study was to determine if a clonal complex (CC) of Staphylococcus aureus or certain virulence and adhesion factors were associated with infections of bones and prosthetic implants. One hundred and nineteen isolates were characterised using microarrays. There was no evidence for a single virulence factor or CC being causative for bone and implant infections. Isolates belonged to 20 different CCs, with CC8 (19.33%), CC45 (17.65%) and CC30 (12.61%) being dominant. Population structure and the relative abundances of virulence genes was similar to previously described isolates from healthy carriers. Differences to carrier isolates included a higher proportion of CC45, a lower proportion of CC15, as well as a higher abundance of sak (staphylokinase) among patient isolates. For 23 patients with infections of total knee or hip prosthetics, it was possible to simultaneously obtain nasal swabs. Fifteen (65.2%) carried S. aureus in their anterior nares. In nine of them (39.1%), isolates from the infection site were identical to carriage isolates. This suggests an elevated risk of infection for S. aureus carriers and the possibility of endogenous infection in a high proportion of them. Therefore, the pre-operative screening and eradication of S. aureus in patients receiving total joint prosthetics should be considered.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sourek J, Výmola F, Trojanová M, Zelenková L, Matĕjovska V, Bergdoll MS (1979) Enterotoxin production by Staphylococcus aureus strains isolated from cases of chronic osteomyelitis. J Clin Microbiol 9:266PubMed Sourek J, Výmola F, Trojanová M, Zelenková L, Matĕjovska V, Bergdoll MS (1979) Enterotoxin production by Staphylococcus aureus strains isolated from cases of chronic osteomyelitis. J Clin Microbiol 9:266PubMed
2.
go back to reference Cunningham R, Cockayne A, Humphreys H (1996) Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol 44:157CrossRefPubMed Cunningham R, Cockayne A, Humphreys H (1996) Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol 44:157CrossRefPubMed
3.
go back to reference Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, Vanhems P, Floret D, Etienne J (2007) Pediatric bone and joint infections caused by Panton–Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 26:1042CrossRefPubMed Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, Vanhems P, Floret D, Etienne J (2007) Pediatric bone and joint infections caused by Panton–Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 26:1042CrossRefPubMed
4.
5.
go back to reference Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16CrossRefPubMed Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16CrossRefPubMed
6.
go back to reference Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68:981CrossRefPubMed Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68:981CrossRefPubMed
7.
go back to reference Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME (2008) Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52:13CrossRefPubMed Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME (2008) Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52:13CrossRefPubMed
8.
go back to reference Swingle EL (1935) Studies on small colony variants of Staphylococcus aureus. J Bacteriol 29:467PubMed Swingle EL (1935) Studies on small colony variants of Staphylococcus aureus. J Bacteriol 29:467PubMed
9.
go back to reference Proctor RA, Balwit JM, Vesga O (1994) Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis 3:302PubMed Proctor RA, Balwit JM, Vesga O (1994) Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis 3:302PubMed
10.
go back to reference von Eiff C, Bettin D, Proctor RA, Rolauffs B, Lindner N, Winkelmann W, Peters G (1997) Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 25:1250CrossRef von Eiff C, Bettin D, Proctor RA, Rolauffs B, Lindner N, Winkelmann W, Peters G (1997) Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 25:1250CrossRef
11.
go back to reference von Eiff C, Proctor RA, Peters G (2000) Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract Suppl 44 von Eiff C, Proctor RA, Peters G (2000) Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract Suppl 44
12.
go back to reference Brandt CM, Duffy MC, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR (1999) Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 74:553CrossRefPubMed Brandt CM, Duffy MC, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR (1999) Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 74:553CrossRefPubMed
13.
go back to reference Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R (2008) DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from Eastern Saxony. Clin Microbiol Infect 14:534CrossRefPubMed Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R (2008) DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from Eastern Saxony. Clin Microbiol Infect 14:534CrossRefPubMed
14.
go back to reference Monecke S, Slickers P, Ehricht R (2008) Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol 53:237–251CrossRefPubMed Monecke S, Slickers P, Ehricht R (2008) Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol 53:237–251CrossRefPubMed
15.
go back to reference Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008PubMed Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008PubMed
16.
go back to reference Robinson DA, Enright MC (2004) Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol 186:1060CrossRefPubMed Robinson DA, Enright MC (2004) Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol 186:1060CrossRefPubMed
17.
go back to reference Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a University Hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442CrossRefPubMed Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a University Hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442CrossRefPubMed
18.
go back to reference Monecke S, Luedicke C, Slickers P, Ehricht R (2009) Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 28:1159CrossRefPubMed Monecke S, Luedicke C, Slickers P, Ehricht R (2009) Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 28:1159CrossRefPubMed
19.
go back to reference Monecke S, Slickers P, Ellington M, Kearns A, Ehricht R (2007) High diversity of Panton–Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clin Microbiol Infect 13:1157CrossRefPubMed Monecke S, Slickers P, Ellington M, Kearns A, Ehricht R (2007) High diversity of Panton–Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clin Microbiol Infect 13:1157CrossRefPubMed
20.
go back to reference Bokarewa MI, Jin T, Tarkowski A (2006) Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol 38:504CrossRefPubMed Bokarewa MI, Jin T, Tarkowski A (2006) Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol 38:504CrossRefPubMed
21.
go back to reference van Wamel WJB, Rooijakkers SHM, Ruyken M, van Kessel KPM, van Strijp JAG (2006) The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on {beta}-hemolysin-converting bacteriophages. J Bacteriol 188:1310CrossRefPubMed van Wamel WJB, Rooijakkers SHM, Ruyken M, van Kessel KPM, van Strijp JAG (2006) The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on {beta}-hemolysin-converting bacteriophages. J Bacteriol 188:1310CrossRefPubMed
22.
go back to reference Coleman D, Knights J, Russell R, Shanley D, Birkbeck TH, Dougan G, Charles I (1991) Insertional inactivation of the Staphylococcus aureus beta-toxin by bacteriophage phi 13 occurs by site- and orientation-specific integration of the phi 13 genome. Mol Microbiol 5:933CrossRefPubMed Coleman D, Knights J, Russell R, Shanley D, Birkbeck TH, Dougan G, Charles I (1991) Insertional inactivation of the Staphylococcus aureus beta-toxin by bacteriophage phi 13 occurs by site- and orientation-specific integration of the phi 13 genome. Mol Microbiol 5:933CrossRefPubMed
23.
go back to reference Coleman DC, Sullivan DJ, Russell RJ, Arbuthnott JP, Carey BF, Pomeroy HM (1989) Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J Gen Microbiol 135:1679PubMed Coleman DC, Sullivan DJ, Russell RJ, Arbuthnott JP, Carey BF, Pomeroy HM (1989) Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J Gen Microbiol 135:1679PubMed
24.
go back to reference Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton–Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128CrossRefPubMed Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton–Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128CrossRefPubMed
25.
go back to reference Larson EL, Hughes CA, Pyrek JD, Sparks SM, Cagatay EU, Bartkus JM (1998) Changes in bacterial flora associated with skin damage on hands of health care personnel. Am J Infect Control 26:513CrossRefPubMed Larson EL, Hughes CA, Pyrek JD, Sparks SM, Cagatay EU, Bartkus JM (1998) Changes in bacterial flora associated with skin damage on hands of health care personnel. Am J Infect Control 26:513CrossRefPubMed
26.
go back to reference van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HFL, Verbrugh HA (2009) Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9:32CrossRefPubMed van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HFL, Verbrugh HA (2009) Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9:32CrossRefPubMed
27.
go back to reference Crossley K (2009) Review: intranasal mupirocin ointment reduces Staphylococcus aureus infections in nasal carriers. Evid Based Med 14:110CrossRefPubMed Crossley K (2009) Review: intranasal mupirocin ointment reduces Staphylococcus aureus infections in nasal carriers. Evid Based Med 14:110CrossRefPubMed
28.
go back to reference van Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev CD006216 van Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev CD006216
Metadata
Title
Molecular fingerprinting of Staphylococcus aureus from bone and joint infections
Authors
C. Luedicke
P. Slickers
R. Ehricht
S. Monecke
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0884-4

Other articles of this Issue 4/2010

European Journal of Clinical Microbiology & Infectious Diseases 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine